MedPath

PYRIBENZAMINE TAB 50MG

PYRIBENZAMINE TAB 50MG

Discontinued
DIN Number

00623504

Drug Class

Human

Market Date

Dec 31, 1947

Company
HC

novartis consumer health canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00623504
AIG Number0107437002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R06AC04 TRIPELENNAMINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification04:04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRIPELENNAMINE HYDROCHLORIDEActive
Strength: 50 MG / TAB
Monograph: TRIPELENNAMINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.